3-amino-2-hydroxy-4-phenylbutanoic acid has been researched along with glycine in 1 studies
| Studies (3-amino-2-hydroxy-4-phenylbutanoic acid) | Trials (3-amino-2-hydroxy-4-phenylbutanoic acid) | Recent Studies (post-2010) (3-amino-2-hydroxy-4-phenylbutanoic acid) | Studies (glycine) | Trials (glycine) | Recent Studies (post-2010) (glycine) |
|---|---|---|---|---|---|
| 42 | 0 | 3 | 35,163 | 756 | 8,415 |
| Protein | Taxonomy | 3-amino-2-hydroxy-4-phenylbutanoic acid (IC50) | glycine (IC50) |
|---|---|---|---|
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 1.4852 | |
| Sodium- and chloride-dependent glycine transporter 1 | Homo sapiens (human) | 106 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.3253 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.3253 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 0.3253 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.3253 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.3253 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.3253 | |
| Sodium- and chloride-dependent glycine transporter 2 | Homo sapiens (human) | 128 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, M; Hayashi, Y; Hidaka, K; Kameoka, M; Kempf, DJ; Kimura, T; Kiso, Y; Kuroki, R; McDaniel, KF; Nguyen, JT; Sankaranarayanan, R; Wang, J | 1 |
1 other study(ies) available for 3-amino-2-hydroxy-4-phenylbutanoic acid and glycine
| Article | Year |
|---|---|
Identification of Highly Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors against Lopinavir and Darunavir Resistant Viruses from Allophenylnorstatine-Based Peptidomimetics with P2 Tetrahydrofuranylglycine.
Topics: Crystallography, X-Ray; Darunavir; Drug Resistance, Viral; Glycine; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Lopinavir; Peptidomimetics; Phenylbutyrates; Serum; Structure-Activity Relationship | 2018 |